CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention Percutaneous coronary intervention using a combination of robotics and telecommunications by an operator in a separate physical location from the patient: an early exploration into the feasibility of telestenting (the REMOTE-PCI study) Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

Guideline26 August 2017

JOURNAL:European Heart Journal Article Link

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed

V. Aboyans, J-B Ricco, M-L E. L. Bartelink et al Keywords: Prevention; Peripheral Vascular Intervention; Peripheral Arterial Diseases

Full Text PDF